| Literature DB >> 33786128 |
Sławomir Poletajew1, Wojciech Krajewski2, Paweł Stelmach3, Jan Adamowicz4, Łukasz Nowak2, Marco Moschini5, Piotr Zapała6, Tomasz Drewa4, Andrzej Paradysz3, Piotr Radziszewski6, Romuald Zdrojowy2, Piotr Kryst1.
Abstract
INTRODUCTION: Transurethral resection of bladder tumour (TURBT) is one of the most commonly performed urologic procedures. Because of the shortcomings of conventional TURBT, the en-bloc resection concept was created. AIM: To analyse the influence of en-bloc technique on surgical and oncological outcomes of TURBT performed with electric current.Entities:
Keywords: bladder cancer; en-bloc; transurethral resection; transurethral resection of bladder tumour
Year: 2020 PMID: 33786128 PMCID: PMC7991935 DOI: 10.5114/wiitm.2020.95399
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Patients’ baseline characteristics and comparison of groups
| Parameter | All patients ( | Conventional TURB ( | En-bloc TURBT ( | |
|---|---|---|---|---|
| Gender (M/F) | 318/109 (74.5/25.5%) | 201/73 (73.4/26.6%) | 117/36 (76.5/23.5%) | 0.9 |
| Age, mean ± SD | 69 ± 1.46 | 69.5 ±11.47 | 68 ±11.39 | 0.4 |
| Primary/recurrent/missing data | 209/205/13 (48.9/48/3.1%) | 115/147/12 (42/53.6/4.4%) | 94/58/1 (61.4/37.9/0.7%) | |
| Previous intravesical chemotherapy (yes/no) | 17/410 (4/96%) | 13/261 (4.7/95.3%) | 4/149 (2.6/97.4%) | 0.1 |
| Previous intravesical BCG (yes/no) | 52/375 (12.2/87.8%) | 39/235 (14.2/85.8%) | 13/140 (8.5/91.5%) | 0.1 |
| Number of tumours (solitary/multiple) | 256/171 (60/40%) | 159/115 (58/42%) | 97/56 (63.4/36.6%) | 0.7 |
| Tumour size (< 3 cm/> 3 cm) | 337/90 (78.9/21.1%) | 208/66 (75.9/24.1%) | 129/24 (84.3/15.7%) | |
| Tumour stage: | ||||
| T0 | 73 (17.1%) | 58 (21.2%) | 15 (9.8%) | |
| Ta | 220 (51.5%) | 126 (46%) | 94 (61.4%) | |
| T1 | 96 (22.5%) | 58 (21.2%) | 38 (24.8%) | 0.383 |
| T2 | 38 (8.9%) | 32 (11.7%) | 6 (3.9%) | |
| Concomitant CIS | 40 (11.3%) | 19 (8.8%) | 21 (15.2%) | 0.063 |
| Tumour grade: | ||||
| G1 | 47 (13.3%) | 21 (9.7%) | 26 (18.8%) | |
| G2 | 184 (52%) | 113 (52.3%) | 71 (51.4%) | 0.9 |
| G3 | 123 (34.7%) | 82 (38%) | 41 (29.7%) | 0.1 |
| Presence of muscularis propria in the specimen | 289 (81.6%) | 163 (75.5%) | 126 (91.3%) | |
| Catheterization time [h], median (SD; mean) | 24 (41.8;37.22) | 24 (46.82;34.55) | 24 (32.1;34.6) | 0.6 |
| Hospitalization time [days], median (SD; mean) | 1 (1.6;1.65) | 1 (1.82;1.89) | 1 (0.9;1.3) | |
| Operation time [min], median (SD; mean) | 30 (17.6;32.6) | 30 (18.3;34.55) | 25 (16;29.6) | |
| reTURBT | 95 (26.8%) | 58 (26.9%) | 37 (26.8%) | 0.9 |
| Residual tumour in reTURBT | 40 (42.1%) | 29 (50%) | 11 (29.7%) | 0.051 |
| 3-month RFS | 368 (83.3%) | 231 (80.1%) | 137 (88.4%) |
M – male, F – female, BCG – Bacillus Calmette-Guerin, CIS – carcinoma in situ, SD – standard deviation, TURBT – transurethral resection of the bladder tumour CIS – carcinoma in situ. The value of adjusted p < 0.05 was considered statistically significant (bolded).
Photo 1A – Papillary tumour, B – circumferential marking of the resection site, finding the appropriate depth of resection, C – mainly blunt dissection within muscular layer, D – resection bed
Group comparisons after propensity score matching
| Parameter | Conventional TURBT ( | En-bloc TURBT ( | |
|---|---|---|---|
| Presence of muscularis propria in the specimen | 95 (68.8%) | 126 (91.3%) | |
| Catheterization time [h], median (SD;mean) | 24 (29.9;33.48) | 24 (31.9;34.4) | 0.2 |
| Hospitalization time [days], median (SD;mean) | 1 (1.13;1.54) | 1 (0.87;1.27) | |
| Operation time [min], median (SD;mean) | 30 (16.2;32.44) | 25 (16.13;29.4) | 0.059 |
| reTURBT | 30 (21.7%) | 37 (26.8%) | 0.3 |
| Residual tumour in reTURBT | 17 (12.3%) | 13 (9.4%) | 0.5 |
| 3-month RFS | 101 (73.2%) | 122 (88.4%) |
SD – standard deviation, TURBT – transurethral resection of the bladder tumour. The value of adjusted p < 0.05 was considered statistically significant (bolded).